Clinical Trials Directory

Trials / Conditions / Unresectable Breast Carcinoma

Unresectable Breast Carcinoma

13 registered clinical trials studyying Unresectable Breast Carcinoma — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingTesting the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-
NCT07137416
National Cancer Institute (NCI)Phase 1
RecruitingA Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combinati
NCT06827236
BioNTech SEPhase 1 / Phase 2
Active Not RecruitingEvaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors
NCT06714617
SystImmune Inc.Phase 1
RecruitingThe COMPASSION Study
NCT06507930
Dana-Farber Cancer InstituteN/A
RecruitingTesting the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Ad
NCT05372640
National Cancer Institute (NCI)Phase 1
Active Not RecruitingIn Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable a
NCT04616248
University of Southern CaliforniaPhase 1
Active Not RecruitingOnvansertib + Paclitaxel In TNBC
NCT05383196
Antonio Giordano, MDPhase 1 / Phase 2
WithdrawnRadiotherapy in Combo With Chemo and Immunotherapy in Patients With PD-L1 Positive Metastatic TNBC
NCT05233696
University of Colorado, DenverPhase 2
Active Not RecruitingNiraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fa
NCT04673448
University of WashingtonPhase 1
RecruitingTesting the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tu
NCT04704661
National Cancer Institute (NCI)Phase 1
Active Not RecruitingAvelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectabl
NCT03971409
Laura Huppert, MD, BAPhase 2
CompletedTesting the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Canc
NCT03199885
National Cancer Institute (NCI)Phase 3
CompletedVeliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer
NCT01149083
National Cancer Institute (NCI)Phase 2